CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-in Capital	Deferred Stock Units	Retained Earnings	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Loss	Treasury Stock	Noncontrolling Interest
Balance beginning of period (in shares) at Dec. 31, 2019			105,711
Balance beginning of period at Dec. 31, 2019	$ 177,825	$ (1,829)	$ 10,571	$ 1,213,517	$ 4,462	$ 1,595,648	$ (1,829)	$ (46,182)	$ (2,600,543)	$ 352
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	582,131					581,776				355
Other comprehensive gain (loss), net	(7,433)							(7,433)
Repurchases of common stock, net	(199,347)								(199,347)
Common stock issued under stock plans, net (in shares)			746
Common stock issued under stock plans, net	50,497		$ 75	51,368	(946)
Deferred stock units activity	0			(894)	894
Share-based compensation cost	30,951			30,858	93
Balance end of period (in shares) at Dec. 31, 2020			106,457
Balance end of period at Dec. 31, 2020	632,795		$ 10,646	1,294,849	4,503	2,175,595		(53,615)	(2,799,890)	707
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	744,844					744,845				(1)
Other comprehensive gain (loss), net	131							131
Acquisition of noncontrolling interest (Note 4)	(990)			(284)						(706)
Repurchases of common stock, net	(770,801)								(770,801)
Common stock issued under stock plans, net (in shares)			421
Common stock issued under stock plans, net	46,258		$ 42	46,228	(12)
Deferred stock units activity	0			(1,035)	1,035
Share-based compensation cost	$ 37,755			37,562	193
Balance end of period (in shares) at Dec. 31, 2021	106,878		106,878
Balance end of period at Dec. 31, 2021	$ 689,992		$ 10,688	1,377,320	5,719	2,920,440		(53,484)	(3,570,691)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	679,089					679,089
Other comprehensive gain (loss), net	(24,312)							(24,312)
Repurchases of common stock, net	(821,421)								(821,421)
Common stock issued under stock plans, net (in shares)			315
Common stock issued under stock plans, net	35,619		$ 31	36,654	(1,066)				0
Deferred stock units activity	0			(459)	459
Share-based compensation cost	$ 49,770			49,700	70
Balance end of period (in shares) at Dec. 31, 2022	107,193		107,193
Balance end of period at Dec. 31, 2022	$ 608,737		$ 10,719	$ 1,463,215	$ 5,182	$ 3,599,529		$ (77,796)	$ (4,392,112)	$ 0